Catalyst Wire Dossier Catalyst Wire Dossier

Neocepri

folic acid · Endocyte Europe, B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neocepri, covering 2014-08-14 to 2014-08-14. Get the full timeline:

Most recent: EMA Application withdrawn: Neocepri (folic acid) — Endocyte Europe, B.V.

See pricing